MedPath

NEOSTIGMINE OMEGA

NEOSTIGMINE OMEGA

Approved
DIN Number

02387166

Drug Class

Human

Market Date

Apr 17, 2013

Company
HC

omega laboratories limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02387166
AIG Number0102263004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07AA01 NEOSTIGMINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous ,  Intravenous ,  Intramuscular
AHFS Classification12:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NEOSTIGMINE METHYLSULFATEActive
Strength: 2.5 MG / ML
Monograph: NEOSTIGMINE METHYLSULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.